2025 annual financial data
BioMarin Pharmaceutical 2025 Net income growth
Direct answer
Net income growth was -18.26%.
Operating income was 533,477,999 USD and net income was 348,901,000 USD.
Operating cash flow was 827,994,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,221,253,000 USD
- Operating income
- 533,477,999 USD
- Net income
- 348,901,000 USD
- Operating cash flow
- 827,994,000 USD